Accelerator™ Drug Development by Thermo Fisher Scientific
Gain speed, simplicity and scalability with our 360° CDMO and CRO solutions
Developing novel therapies and bringing them to patients is a high-risk process. Working across multiple vendors can extend an already lengthy drug development process, creating additional decision-making, timeline gaps and overall progress challenges.
That’s why sponsors need a streamlined clinical research, drug development and manufacturing organization solution combining the expertise and technology of a clinical research organization (CRO) and contract development and manufacturing organization (CDMO), delivering speed, simplicity and scalability to clinical trials, drug development and manufacturing.
Coordinating activities across all stages of drug development with one partner for your CDMO and CRO solutions ensures simplified and scalable pathways, from concept to market.
Streamline your drug development with our 360° CDMO and CRO solutions
Working with one partner for your CDMO and CRO solutions provides sponsors with a wide range of innovative capabilities, improving speed, simplicity, and scalability, streamlining and de-risking your drug development journey from molecule to medicine to market.
Benefits of our Accelerator™ Drug Development, 360° CDMO and CRO solutions:
- Accelerating IND filing and Phase I startup with expert consulting and manufacturing services
- Aligning on site selection, patient enrollment and clinical trial supplies to exceed customer expectations on site activation timing and first patient in targets
- Matching the demand for clinical trial supplies at each site with the actual supply and accurate delivery timing, consistently meeting trial and patient needs
- Providing total program visibility, avoiding unnecessary spending, and minimizing trial supply waste
- Simplifying sponsor’s administrative tasks by eliminating multiple vendor contracts, reducing meeting times and centralizing program management and governance functions
- Integrated timelines, joint project management and streamlined information sharing
- Expedited communication within the integrated structure
- Proactive risk mitigation and swift adaptation of strategies
- Faster decision making enabled by visibility of key project milestones
- Centralized coordination across programs
- Reduction of multiple vendor handoffs
- Transparency across supply chains
- Experts to guide and de-risk your asset development program
- Joint contracts across development, manufacturing, clinical supply, clinical research and consulting services
- Global networks with regional expertise across geographies
- Seamless scale-up across all phases of clinical trials through to commercialization
The right partner for your drug development success
Choosing the right partner is critical to your success. At Thermo Fisher Scientific, we are a global, full-service and functional service provider (FSP), CRO and CDMO partner, helping you accelerate the development of your unique small molecule, large molecule and advanced therapies, supporting your aspiration to get your innovative treatments to patients faster.
- Decades of expertise across all areas of drug development, manufacturing and clinical trials in one company
- A trusted partner who can flex and grow with your project, as needed
- Rigorous operational oversight to manage your project timelines and proactively mitigate project risks
Best-in-class expertise backed by decades of experience bringing innovative therapies to market globally
The PPD clinical research business of Thermo Fisher Scientific
- Worked on 10 out of 10 of the top selling drugs of 2022
- Conducted more than 2,800 clinical trials in the past five years
- Worked on more than 7,600 compounds in the past five years
- Was involved in 92 global drug approvals in 2022
- Works with 50 of top 50 pharma and 500+ biotech
The Patheon pharma services business of Thermo Fisher Scientific
- Has supported more than 7,100 clinical trials
- Has more than 1,100 customers from 80 countries
- Works with primarily new and emerging customers (90%)
- Works with all top 20 pharmaceutical companies
- Has twice as many NDA approvals than the next largest CDMO
Simplify your asset development journey with Accelerator™ Drug Development, 360° CDMO and CRO solutions
Through our integrated CRO and CDMO solutions, we provide a complete suite of services to take your asset from research to market, streamlining timelines, proactively mitigating risks, eliminating handoffs between multiple vendors, simplifying contracts and centralizing program management.
Recommended for you
